Artificial intelligence (AI) and deep learning models may help to predict the risk of cardiovascular disease events and detect heart valvular disease, according to two preliminary research studies.
November 06, 2023
AI May Accurately Detect Heart Valve Disease and Predict Cardiovascular Risk
November 6, 2023 — Advances in artificial intelligence have enabled the development and application of AI tools that…
Read More
New clinical analyses and real-world data continue to demonstrate the benefit of treatment with CAMZYOS (mavacamten) for patients with symptomatic obstructive HCM
November 06, 2023
Bristol Myers Squibb to Present Data from Innovative Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2023
November 6, 2023 —  Bristol Myers Squibb  announced that research across the company’s cardiovascular franchise will be…
Read More
Study suggests CV risk factors and comorbidities could contribute to progression to dementia
November 06, 2023
New Atrial Fibrillation Diagnosis May Increase risk of Memory Decline
November 6, 2023 — Atrial fibrillation (AF) diagnosis was associated with a 45% increased risk of mild cognitive…
Read More
Medical University of South Carolina researchers partner with Emergency Medical Services to pilot test the first MRI-equipped ambulance to speed stroke response
November 03, 2023
An MRI-equipped Ambulance: A Game-changer for Stroke Care?
November 3, 2023 — In the U.S., someone has a stroke every 40 seconds and dies from it every three minutes and 14…
Read More
Marlene Rabinovitch, MD, Stanford University
November 03, 2023
Dr. Marlene Rabinovitch to Receive the 2023 AHA Research Achievement Award
November 3, 2023 — The American Heart Association will present its 2023 Research Achievement Award to Marlene…
Read More
New Board of Cardiovascular Medicine will certify cardiovascular medicine physicians with more specific and more competency-based trainings and supports
November 03, 2023
The American Heart Association Joins Consortium with Full Support for a New American Board of Cardiovascular Medicine
November 3, 2023 — The national Board of Directors of the American Heart Association last week voted to provide full…
Read More
November 02, 2023
Data from VIVA23 Late-breaking Clinical Trial Focuses on Computer-Assisted Vacuum Thrombectomy for Pulmonary Embolism
November 2, 2023 — The latest STRIKE-PE data, presented by Penumbra, Inc. at the Vascular Interventional Advances…
Read More
The University of Maryland Medical Center released a statement on the Oct. 30 passing of Lawrence Faucette, a 58-year-old patient with terminal heart disease who received the world’s second genetically-modified pig heart transplant Sept. 20 in a landmark cardiac xenotransplantation procedure.
November 02, 2023
UMMC Issues Statement on Passing of Man Who Received Second Pig Heart Transplant, Mourns Loss of Remarkable Patient, Scientist, Navy Veteran
November 2, 2023 — The University of Maryland Medical Center (UMMC) released a statement on the passing of a patient…
Read More
Results of the PERFORMANCE II Trial were presented by William Gray, MD, System Chief, Division of Cardiovascular Diseases, Main Line Health, and Co-National Principal Investigator during the VIVA23 annual conference..
November 02, 2023
PERFORMANCE II Carotid Stent Trial One-Year Outcomes Released at VIVA23
November 2, 2023 — Contego Medical Inc. announced the presentation of late-breaking clinical results from the…
Read More
November 01, 2023
VIVA23 Presents Outcomes of Late-breaking Science from Abbott’s LIFE-BTK, RESOLV FIH Study, and IN.PACT AV Access Trial
November 2, 2023 — The second round of late-breaking clinical trials results from the Vascular InterVentional Advances…
Read More
November 01, 2023
Vascular InterVentional Advances Conference, VIVA23, Clinical Trial Outcomes: PROMISE II (LimFlow) Trial for TADV, PRELUDE Study (LimbSonic) Therapeutic Ultrasound Presented
November 1, 2023 — The VIVA Foundation has announced the results for the first Late-Breaking Clinical Trial sessions at…
Read More
October 31, 2023
Late-Breaking Clinical Trial outcomes from The VEINS Conference: CLOUT Registry, VIVID Trial, DEXTERITY-AFP Trial, and Venous Thromboembolism Treatment
October 31, 2023 — Results of four late-breaking clinical trials presented during the The VEINS Conference 2023, taking…
Read More
Edwards Lifesciences Corporation (NYSE: EW) announced one-year results from CLASP IID, the first randomized controlled trial that directly compares two contemporary mitral transcatheter edge-to-edge repair (TEER) therapies
October 31, 2023
CLASP IID One-year Data Confirm Safety and Efficacy of Edwards Pascal System for Degenerative Mitral Regurgitation
October 31, 2023 — Edwards Lifesciences Corporation announced one-year results from CLASP IID, the first randomized…
Read More
The findings will impact the interventional treatment of High Bleeding Risk patients
October 31, 2023
Positive Results Revealed in Clinical Trial COMPARE 60/80 for High Bleeding Risk Patients
October 31, 2023 — SMT (Sahajanand Medical Technologies), a leading medical device company in India, focused on…
Read More
The findings will impact the interventional treatment of High Bleeding Risk patients
October 31, 2023
Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
October 31, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover,…
Read More
October 30, 2023
Shockwave Medical Debuts Enhanced Catheter at TCT 2023, Announces Clinical Research Validation
October 30, 2023 — Shockwave Medical, Inc., which develops technologies for the treatment of cardiovascular disease,…
Read More
Data from first coronary DCB study in U.S. meet 12-month primary endpoint, demonstrate low adverse event rates with AGENT DCB
October 30, 2023
Boston Scientific AGENT Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial
October 30, 2023 — Boston Scientific Corporation on Friday announced positive 12-month results from the pivotal AGENT…
Read More
Abbott's landmark LIFE-BTK randomized clinical trial met its primary safety and effectiveness endpoints, demonstrating that Esprit BTK offers significant advancements in opening and keeping blocked arteries below-the-knee open compared to the standard of care, balloon angioplasty
October 30, 2023
Late-breaking Data Show Esprit BTK Drug-eluting Resorbable Scaffold Reduces Chronic Limb-threatening Ischemia Progression Compared to the Standard of Care
October 30, 2023 — Abbott announced late-breaking data from the LIFE-BTK clinical trial evaluating the Esprit BTK…
Read More
Key findings demonstrate patients with aortic stenosis have substantial untreated mortality risk across all levels of aortic stenosis severity, but aortic valve replacement rates remain low even for patients with severe aortic stenosis
October 30, 2023
Philippe Généreux, MD Presents Novel Research on Aortic Stenosis from egnite, Inc.’s Database at TCT23
October 30, 2023 — -egnite, Inc., a leading cardiovascular digital health company, announced today that novel research…
Read More
WATCH TAVR trial presented at the Transcatheter Cardiovascular Therapeutics annual conference
October 26, 2023
iFR and FFR are Equally Safe to Diagnose and Treat Heart Disease According to Largest-ever Analysis of New Real-world, Long-term Data
October 26, 2023 —  Royal Philips, a global leader in health technology, announced the latest results demonstrating the…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now